rs769280599
Variant summary
Our verdict is Pathogenic. Variant got 13 ACMG points: 13P and 0B. PM1PM2PM4_SupportingPP5_Very_Strong
The NM_000018.4(ACADVL):c.833_835delAGA(p.Lys278del) variant causes a disruptive inframe deletion change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000298 in 1,613,012 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★★).
Frequency
Consequence
NM_000018.4 disruptive_inframe_deletion
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 13 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000789 AC: 12AN: 152106Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 251438Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135910
GnomAD4 exome AF: 0.0000246 AC: 36AN: 1460906Hom.: 0 AF XY: 0.0000316 AC XY: 23AN XY: 726760
GnomAD4 genome AF: 0.0000789 AC: 12AN: 152106Hom.: 0 Cov.: 32 AF XY: 0.0000942 AC XY: 7AN XY: 74304
ClinVar
Submissions by phenotype
Very long chain acyl-CoA dehydrogenase deficiency Pathogenic:8
Variant summary: ACADVL c.833_835delAGA (p.Lys278del) results in an in-frame deletion that is predicted to remove one amino acid from the Acyl-CoA oxidase/dehydrogenase, middle domain (IPR006091) of the encoded protein. The variant allele was found at a frequency of 2e-05 in 251438 control chromosomes. c.833_835delAGA has been reported in the literature as a biallelic genotype in multiple individuals affected with Very Long Chain Acyl-CoA Dehydrogenase Deficiency. These data indicate that the variant is very likely to be associated with disease. The following publications have been ascertained in the context of this evaluation (PMID: 24305961, 32463482, 19327992, 10407852). Eight submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as pathogenic. -
This variant, c.833_835del, results in the deletion of 1 amino acid(s) of the ACADVL protein (p.Lys278del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs769280599, gnomAD 0.01%). This variant has been observed in individual(s) with VLCAD deficiency (PMID: 9973285, 19327992, 23430950, 30194637). ClinVar contains an entry for this variant (Variation ID: 281042). For these reasons, this variant has been classified as Pathogenic. -
- -
The NM_000018.3:c.833_835delAGA (NP_000009.1:p.Lys278del) [GRCH38: NC_000017.11:g.7222257_7222259delAGA] variant in ACADVL gene is interpretated to be Pathogenic based on ACMG guidelines (PMID: 25741868). This variant has been reported in PMID: 9973285. This variant meets the following evidence codes reported in the ACMG guidelines: PVS1, PS3 -
- -
- -
The NM_000018.4 c.833_835del (p.Lys278del) variant in ACADVL is an in-frame deletion (removes amino acids Lys278) in exon 9/20 that is not predicted to impact splicing (SpliceAI: 0.01). The highest population minor allele frequency in gnomAD v2.1.1 is 0.0001 in African/African American population, which is lower than the ClinGen ACADVL Variant Curation Expert Panel threshold (<0.001) for PM2_Supporting, meeting this criterion (PM2_Supporting). The c.833_835del variant is predicted to cause a change in the length of the protein (p.Lys278del) due to an in-frame deletion of an amino acid in a non-repeat region (PM4). This variant is reported in the literature in multiple individuals affected with very long-chain acyl-CoA dehydrogenase deficiency in both compound heterozygous and homozygous fashion, with at least one of whom displayed elevated C14:1 carnitine level (1.3 µmol/L) and reduced VLCAD enzyme levels (17% WT control), which is highly specific for VLCAD deficiency (PP4_Moderate, PMID: 19327992). This patient also carried a pathogenic variant c.1376G>A in trans (PM3 score = 1.0, PM3, PMID: 19327992). In summary, this variant meets the criteria to be classified as likely pathogenic for autosomal recessive very long chain acyl-CoA dehydrogenase (VLCAD) deficiency based on the ACMG/AMP criteria applied, as specified by the ClinGen ACADVL Variant Curation Expert Panel: PM2_Supporting, PM4, PP4_Moderate, PM3 (ACADVL VCEP specifications version 1; approved November 9, 2021). -
- -
not provided Pathogenic:2Uncertain:1
- -
ACADVL: PM3:Very Strong, PM2, PP4:Moderate, PM4:Supporting -
Not observed at a significant frequency in large population cohorts (Lek et al., 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; In-frame deletion of one amino acid in a non-repeat region predicted to critically alter the protein; This variant is associated with the following publications: (PMID: 19327992, 32463482, 30194637, 23430950, 9973285, 24305961) -
ACADVL-related disorder Pathogenic:1
The ACADVL c.833_835delAGA variant is predicted to result in an in-frame deletion (p.Lys278del). This variant has been reported in multiple individuals with Very long chain acyl-CoA dehydrogenase deficiency (see for example, Andresen et al 1999. PubMed ID: 9973285; Laforêt et al. 2009. PubMed ID: 19327992). This variant is reported in 0.012% of alleles in individuals of African descent in gnomAD (http://gnomad.broadinstitute.org/variant/17-7125572-GAGA-G). This variant is interpreted as pathogenic. -
Inborn genetic diseases Pathogenic:1
The c.833_835delAGA (p.K278del) alteration, located in coding exon 9 of the ACADVL gene, results from an in-frame deletion of 3 nucleotides at positions 833 to 835. This results in the deletion of a lysine residue at codon 278. Based on data from gnomAD, the c.833_835delAGA allele has an overall frequency of <0.01% (5/251438) total alleles studied. The highest observed frequency was 0.01% (2/16252) of African alleles. This mutation was identified in several individuals with very long-chain acyl-CoA dehydrogenase deficiency, in the both the homozygous and compound heterozygous state, with reduced enzyme activity compared to wild type (Laforêt, 2009; Zweers, 2012; Diekman, 2014; Diekman, 2016; Hesse, 2018; Knottnerus, 2020). In addition, this alteration is predicted to be deleterious by in silico analysis (Choi, 2012). Based on the available evidence, this alteration is classified as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at